Literature DB >> 12726843

Determination of amphetamines in human urine by headspace solid-phase microextraction and gas chromatography.

Nikolaos Raikos1, Klio Christopoulou, Georgios Theodoridis, Heleni Tsoukali, Dimitrios Psaroulis.   

Abstract

Solid-phase microextraction (SPME) is under investigation for its usefulness in the determination of a widening variety of volatile and semivolatile analytes in biological fluids and materials. Semivolatiles are increasingly under study as analytical targets, and difficulties with small partition coefficients and long equilibration times have been identified. Amphetamines were selected as semivolatiles exhibiting these limitations and methods to optimize their determination were investigated. A 100- micro m polydimethylsiloxane (PDMS)-coated SPME fiber was used for the extraction of the amphetamines from human urine. Amphetamine determination was made using gas chromatography (GC) with flame-ionization detection (FID). Temperature, time and salt saturation were optimized to obtain consistent extraction. A simple procedure for the analysis of amphetamine (AMP) and methamphetamine (MA) in urine was developed and another for 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-methamphetamine (MDMA) and 3,4-methylenedioxy-N-ethylamphetamine (MDEA) using headspace solid-phase microextraction (HS-SPME) and GC-FID. Higher recoveries were obtained for amphetamine (19.5-47%) and methamphetamine (20-38.1%) than MDA (5.1-6.6%), MDMA (7-9.6%) and MDEA (5.4-9.6%).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12726843     DOI: 10.1016/s1570-0232(03)00047-3

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  1 in total

1.  Urinary bio-monitoring of amphetamine derivatives by needle trap device packed with the zirconium-based metal-organic framework.

Authors:  Razzagh Rahimpoor; Ali Firoozichahak; Saber Alizadeh; Davood Nematollahi
Journal:  Sci Rep       Date:  2022-08-11       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.